IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2019

IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization

Résumé

The contribution of mast cells in the microenvironment of solid malignancies remains controversial. Here we functionally assess the impact of tumor-adjacent, submucosal mast cell accumulation in murine and human intestinal-type gastric cancer. We find that genetic ablation or therapeutic inactivation of mast cells suppresses accumulation of tumor-associated macrophages, reduces tumor cell proliferation and angiogenesis, and diminishes tumor burden. Mast cells are activated by interleukin (IL)-33, an alarmin produced by the tumor epithelium in response to the inflammatory cytokine IL-11, which is required for the growth of gastric cancers in mice. Accordingly, ablation of the cognate IL-33 receptor St2 limits tumor growth, and reduces mast cell-dependent production and release of the macrophage-attracting factors Csf2, Ccl3, and Il6. Conversely, genetic or therapeutic macrophage depletion reduces tumor burden without affecting mast cell abundance. Therefore, tumor-derived IL-33 sustains a mast cell and macrophage-dependent signaling cascade that is amenable for the treatment of gastric cancer.

Dates et versions

hal-02386396 , version 1 (29-11-2019)

Identifiants

Citer

Moritz Eissmann, Christine Dijkstra, Andrew Jarnicki, Toby Phesse, Jamina Brunnberg, et al.. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization. Nature Communications, 2019, 10 (1), pp.2735. ⟨10.1038/s41467-019-10676-1⟩. ⟨hal-02386396⟩

Collections

INFINITY
54 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More